Presentación de PowerPoint · Life expectancy at birth: •Men: 70.4 y (2013) •Women: 77.2 y...

5
HIV/AIDS: COLOMBIA A VIEW OF OUR COUNTRY Andrés F. Sánchez Vera MD HIV Physician - Epidemiologist [email protected] Guillermo León Basantes Internal Medicine - Epidemiologist [email protected]

Transcript of Presentación de PowerPoint · Life expectancy at birth: •Men: 70.4 y (2013) •Women: 77.2 y...

Page 1: Presentación de PowerPoint · Life expectancy at birth: •Men: 70.4 y (2013) •Women: 77.2 y (2013) Age for retirement pension (since 2014): •Men: 62 Years Women: 57 Years

HIV/AIDS: COLOMBIAA VIEW OF OUR COUNTRY

Andrés F. Sánchez Vera MD

HIV Physician - Epidemiologist

[email protected]

Guillermo León Basantes

Internal Medicine - Epidemiologist

[email protected]

Page 2: Presentación de PowerPoint · Life expectancy at birth: •Men: 70.4 y (2013) •Women: 77.2 y (2013) Age for retirement pension (since 2014): •Men: 62 Years Women: 57 Years

Life expectancy at birth:

• Men: 70.4 y (2013)

• Women: 77.2 y (2013)

Age for retirement pension (since 2014):

• Men: 62 Years Women: 57 Years

Population (2014)

• 48.929.706 people.

Health regimes: covers91.3% of population

• Subsidized - Contributory

• Special - Prepaid.

General Data

From Colombia to the World

Strengths

• Democratic ways

• People: Human Resource

Difficulties

• Armed Conflict – ForcedMigration

• Corruption

• Inequality

Page 3: Presentación de PowerPoint · Life expectancy at birth: •Men: 70.4 y (2013) •Women: 77.2 y (2013) Age for retirement pension (since 2014): •Men: 62 Years Women: 57 Years

HIV Colombian people: 120,000

Children withHIV: 2400

Prevalence in adults: 0.4%

Deaths: 4700 Women/Men: 1:3• ONU-SIDA. Informe Colombia. 2014.

http://www.unaids.org/es/regionscountries/countries/colombia/

What about of HIV in Colombia?

Page 4: Presentación de PowerPoint · Life expectancy at birth: •Men: 70.4 y (2013) •Women: 77.2 y (2013) Age for retirement pension (since 2014): •Men: 62 Years Women: 57 Years

What about of HIV in Colombia?

New releases HIV and HCV

• Atripla, Complera, Stribild, Dolutegravir

• Simeprevir

Two new clinicalpractice guidelines(2014)

• HLA B5701 not included

Low Prevalence of allergic reactions.

ANTIRETROVIRAL DRUGS – WHAT DO WE HAVE?

INTR NNRTISPROTEASE INHIBITORS

ENTRY INHIBITORS

INTEGRASE INHIBITORS

STAVUDINE EFAVIRENZ SAQUINAVIR ENFUVIRTIDE RALTEGRAVIR

ZALCITABINE NEVIRAPINE INDINAVIR MARAVIROC DOLUTEGRAVIR

DIDANOSINE ETRAVIRINE NELFINAVIR ELVITEGRAVIR

LAMIVUDINE RILPIVIRINE AMPRENAVIR

ZIDOVUDINE LOPINAVIR/R

ABACAVIR ATAZANAVIR

EMTRICITABINE FOSAMPRENAVIR

TENOFOVIR DARUNAVIR

Page 5: Presentación de PowerPoint · Life expectancy at birth: •Men: 70.4 y (2013) •Women: 77.2 y (2013) Age for retirement pension (since 2014): •Men: 62 Years Women: 57 Years

Our challenges for the coming years

Reduce sexual transmission of HIV by half by 2015

Eliminate mother to child transmission of HIV by 2015 and reducesubstantially maternal deaths related to AIDS

Ensure that people living with HIV continue treatment

Reduce by half the deaths from tuberculosis among people who are living with HIV in 2015.

• World report on progress in the fight against AIDS. Colombia 2012. UNGASS Report.

Thanks!